Listar por autor "Steigbigel, Roy T."
Mostrando ítems 1-4 de 4
-
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the benchmrk studies: final results of two randomised, placebo-controlled trials
Eron, Joseph J. et al. | Fecha del documento: 2013 -
Long-term efficacy and safety of raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 phase III trials
Steigbigel, Roy T. et al. | Fecha del documento: 2010 -
Raltegravir with optimized background therapy for resistant HIV-1 infection
Steigbigel, Roy T. et al. | Fecha del documento: 2008 -
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection
Cooper, David A. et al. | Fecha del documento: 2008